Outcome predictor factors in the treatment of obsessive-compulsive disorder using behavior and cognitive-behavior therapies: A systematic review;Fatores preditores de resultados no tratamento do transtorno obsessivo-compulsivo com as terapias comportamental e cognitivo-comportamental: Uma revisão sistemática

Revista de Psiquiatria do Rio Grande do Sul

Volumn 30, Issue 1 SUPPL., 2008, Pages

  Raffin, Andréa Litvin ^a,c   Ferrão, Ygor Arzeno ^b   De Souza, Fernanda Pasquoto ^a   Cordioli, Aristides Volpato ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Centro Universitário Metodista Instituto Porto Alegre

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Behavior therapy; Cognitive behavior therapy; Exposure and response prevention; Obsessive compulsive disorder; Prognosis

Indexed keywords

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; HUMAN; MOTIVATION; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PROGNOSIS; REVIEW; SCHIZOTYPAL PERSONALITY DISORDER; SEX DIFFERENCE; SYSTEMATIC REVIEW;

EID: 58149240565     PISSN: 01018108     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0101-81082008000200006     Document Type: Review

References (52)

1. a ed rev. Porto Alegre: Artmed; 2002.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593-602.
3. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry. 1996;169(1):107-7.
4. March JS, Frances A, Kahn DA, Carpenter D. The expert consensus guideline series: treatment of obsessive-compulsive disorder. J Clin Psychiatry. 1997;58(Suppl 4):3-72.
5. Clomipramine in the treatment of obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry. 1991;48(8):730-8.
6. Eisen JL, Goodman WK, Keller MB, Warshaw MG, De Marco LM, Luce DD, et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry. 1999;60(5):346-51.
7. Pigott T, Seay S. Pharmacotherapy of obsessive-compulsive disorder: overview and treatment-refractory strategies. In: Goodman WK, Rudorfer MV, Maser JD. Obsessive-compulsive disorder - contemporary issues in treatment. London: Lawrence Erlbaum Associates; 2000. p. 277-82.
8. Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry. 1988;145(12):1521-5.
9. Foa EB. Failures in treating obsessive-compulsives. Behav Res Ther. 1979;17:169:76.
10. Abramowitz J. Effectiveness of psychological and pharmacological treatments for obsessivecompulsive disorder: a quantitative review. J Consult Clin Psychol. 1997;65(1):44-52.
11. Asbahr FR, Castillo AR, Ito LM, Latorre MR, Moreira MN, Lotufo-Neto F. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1128-36.
12. Souza MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(7):1133-9.
13. Braga DT, Cordioli AV, Niederauer K, Manfro GG. Cognitive-behavioral group therapy for obsessive-compulsive disorder: a 1-year follow-up. Acta Psychiatr Scand. 2005:112(3):180-6.
14. Falls-Stewart W, Marks AP, Schafer J. A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. J Nerv Ment Dis. 1993;181(3):189-93.
15. Emmelkamp PMG, Bouman TK, Blaauw E. Individualized versus standardized therapy: a comparative evaluation with obsessive-compulsive patients. Clin Psychol Psychother. 1994;1:95-100.
16. Volpato Cordioli A, Heldt E, Braga Bochi D, Margis R, Basso de Sousa M, Fonseca Tonello J, et al. Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial. Psychother Psychosom. 2003;72(4):211-6.
17. Foa EB, Grayson JB, Steketee GS, Doppelt HG, Turner RM, Latimer PR. Success and failure in the behavioral treatment of obsessive-compulsives. J Consult Clin Psychol. 1983;51(2):287-97.
18. Cordioli AV, Heldt E, Bochi DB, Margis R, Sousa MB, Tonello JF, et al. Cognitive-behavioral group therapy in obsessive-compulsive disorder: a clinical trial. Rev Bras Psiquiatr. 2002;24(3):113-20.
19. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R. Clomipramine and exposure for for obsessive-compulsive rituals. Br J Psychiatry. 1980;136:1-25.
20. Mawson D, Marks IM, Ramm L. Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings. Br J Psychiatry. 1982;140:11-18.
21. Minichiello WE, Baer L, Jenike MA. Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anx Disorders. 1987;1:273-6.
22. Basoglu M, Lax T, Kasvikis Y, Marks IM. Predictors of improvement in obsessive-compulsive disorder. J Anx Disorders. 1988;2:299-317.
23. O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. Six-year follow-up after exposure and clomipramine therapy for obsessive-compulsive disorder. J Clin Psychiatry. 1991;52(4):150-5.
24. Foa EB, Kozak MJ, Steketee GS, McCarthy PR. Treatment of depressive and obsessivecompulsive symptoms in OCD by imipramine and behaviour therapy. Br J Clin Psychol. 1992;31(Pt 3):279-92.
25. Cottraux J, Messy P, Marks IM, Mollard E, Bouvard M. Predictive factors in the treatment of obsessive-compulsive disorders with fluvoxamine and or behavior therapy. Behav Psychother. 1993;21:45-50.
26. Keijsers GP, Hoogduin CA, Schaap CP. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry. 1994;165(6):781-6.
27. Castle DJ, Deale A, Marks IM, Cutts F, Chadhoury Y, Stewart A. Obsessive-compulsive disorder: prediction of out-come from behavioural psychotherapy. Acta Psychiatr Scand. 1994;89(6):393-8.
28. Buchanan AW, Meng KS, Marks IM. What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety. 1996;2(1):22-7.
29. de Araújo LA, Ito LM, Marks IM. Early compliance and other factors predicting outcome of exposure for obsessive-compulsive disorder. Br J Psychiatry. 1996;169(6):747-52.
30. de Haan E, van Oppen P, van Balkom AJ, Spinhoven P, Hoogduin KA, Van Dyck R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatr Scand. 1997;96(5):354-61.
31. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, et al. FDG-PET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res Neuroimaging. 1998;84(1):1-6.
32. Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry. 1998;59(8):420-5.
33. Neziroglu FA, Stevens KP, Yaryura-Tobias JA. Overvalued ideas and their impact on treatment outcome. Rev Bras Psiquiatr. 1999;21(4):209-16.
34. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56:121-7.
35. Steketee G, Eisen J, Dyck I, Warshaw M, Rasmussen S. Predictors of course in obsessive-compulsive disorder. Psychiatry Res. 1999;89(3):229-38.
36. Foa EB, Abramowitz JS, Franklin ME, Kosak MJ. Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behav Ther. 1999; 30(4):717-24.
37. Abramowitz JS, Franklin ME, Street GP, Kosak MJ, Foa EB. Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behav Ther. 2000;31(3):517-28.
38. Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62(7):535-40.
39. McLean PD, Whittal ML, Thordarson DS, Taylor S, Söchting I, Koch WJ, et al. Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. J Consult Clin Psychol. 2001;69:205-14.
40. Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, et al. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry. 2002;63(1):21-7.
41. Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry. 2002;63 Suppl 6:20-9.
42. Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand. 2006;113(5):440-6.
43. Ferrão YA, Shavitt RG, Bedin NR, de Mathis ME, Carlos Lopes A, Fontenelle LF, et al. Clinical features of refractory obsessive-compulsive patients. J Affect Disord. 2006;94(1-3):199-209.
44. Grant JE, Mancebo MC, Pinto A, Williams KA, Eisen JL, Rasmussen SA. Late-onset obsessive compulsive disorder: clinical characteristics and psychiatric comorbidity. Psychiatry Res. 2007;152(1):21-7.
45. Fontenelle LF, Marques C, Versiani M. The effect of gender on the clinical features and therapeutic response in obsessive-compulsive disorder. Rev Bras Psiquiatr. 2002;24(1):7-11.
46. Rosário-Campos MC, Leckman JF, Mercadante MT, Shavitt RG, Prado HS, Sada P, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158(11):1899-903.
47. Miranda MA. Transtorno obsessivo-compulsivo e comorbidade: um estudo caso-controle [tese]. São Paulo (SP): Universidade Federal de São Paulo, Escola Paulista de Medicina; 1999.
48. Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's syndrome. J Clin Psychiatry. 1995;56(6):256-55.
49. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, et al. Phenomenological differences appearing with repetitive behaviors in obsessive-compulsive disorder and Gilles de la Tourette syndrome. Br J Psychiatry. 1997;170:140-5.
50. Miguel EC, do Rosário-Campos MC, Shavitt RG, Hounie AG, Mercadante MT. The tic-related obsessive-compulsive disorder phenotype. Adv Neurol. 2001;85:43-55.
51. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49(9):681-9.
52. Fletcher RH, Fletcher SW, Wagner EH. Epidemiologia clínica: elementos essenciais. 3rd ed. Porto Alegre: Artmed; 1996.